Home » Topics » Regulatory

Regulatory
RSS

Orion receives EU approval to market Parkinson's disease treatment

Sep. 21, 1998

Early 1999 launch dates anticipated for EchoGen in European markets

Sep. 18, 1998

Novel use for a known antidepressant: doxepin relieves pruritus in patients with eczema

Sep. 18, 1998

Nasal calcitonin reduces spinal fractures in postmenopausal women with osteoporosis

Sep. 17, 1998

FDA clears diagnostic for DVT - a potentially life-threatening disorder

Sep. 16, 1998

Pylorid-containing triple therapy effective in eradicating H. pylori

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

FDA approves, HMR begins shipping new treatment for adult rheumatoid arthritis

Sep. 14, 1998

Glaxo Wellcome receives first marketing approval for new asthma therapeutic

Sep. 14, 1998

CHF treatment now available in the U.K.

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...